The effect of KYNAMRO on cardiovascular morbidity and mortality has not been determined.

FORBES: FDA Approves Mipomersen For Homozygous Familial Hypercholesterolemia

The effect of JUXTAPID on cardiovascular morbidity and mortality has not been determined.

FORBES: FDA Approves Lomitapide For Homozygous Familial Hypercholesterolemia

Effects of valsartan on cardiovascular morbidity and mortality in high-risk hyper- tensive patients with new-onset diabetes mellitus: Sub-analysis of the KYOTO HEART Study.

FORBES: Two Retractions For Embattled Chief Investigator Of Kyoto Heart Study